EMEA-001853-PIP01-15-M01

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Human normal immunoglobulin

Decision numberP/0380/2017
PIP numberEMEA-001853-PIP01-15-M01
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Treatment of primary immunodeficiency

Route(s) of administrationSubcutaneous use
PIP applicant

Grifols Therapeutics Inc.
Tel. +49 69660593405
E-mail: bernhard.lauven@grifols.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision